3B Blackbio Dx share news, announcements and annual reports
NSE: 3BBLACKBIOBSE: 532067Healthcare ServicesSmall Cap
3B Blackbio Dx Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1996
Last close ₹1,359.20down ₹3.80 (0.28%)BSE ₹1,359.45
Share price at the NSE close on 29 Oct 2026. Previous close ₹1,363.00.
29 Oct: open ₹1,387.70, high ₹1,387.70, low ₹1,330.60
52-week range of BSE trades to 29 Oct 2026
₹1,083.50Low, 2 Jun 2026₹1,750.00High, 19 Jan 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,167 Cr1,399th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 21.01
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.60
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.37%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 18.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 7,67449.0% delivered
3B Blackbio Dx share news and announcements
778 announcements, routine notices left out, newest first. Page 5 of 16.
Feb 2023
Jan 2023
25 Jan
Dec 2022
Nov 2022
29 Nov
12 Nov
3 Nov · Board meeting
Meeting on 12 Nov 2022: quarterly results
Oct 2022
10 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2022
29 Sep · Notice Of The Meeting Of The Equity Shareholders Of Kilpest India Limited ('Transferee Company') To Be Convened In Accordance With The Order Of The Hon'Ble National Company Law Tribunal, Indore Bench.
22 Sep · Management
22 Sep · Investor's Presentation
Aug 2022
27 Aug · Meeting
27 Aug · Corporate action
27 Aug · Meeting
18 Aug
1 Aug · Board meeting
Meeting on 10 Aug 2022: quarterly results
Jul 2022
7 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2022
May 2022
27 May · Dividend
27 May · Board meeting
27 May
11 May
11 May · Business
Apr 2022
22 Apr · Board meeting
Meeting on 27 May 2022: audited results and final dividend22 Apr · Board meeting
9 Apr · Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Mar 2022
28 Mar